Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Rxsight Inc (RXST)

Rxsight Inc (RXST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 331,668
  • Shares Outstanding, K 27,639
  • Annual Sales, $ 22,590 K
  • Annual Income, $ -48,690 K
  • 60-Month Beta 0.20
  • Price/Sales 14.09
  • Price/Cash Flow N/A
  • Price/Book 2.88
Trade RXST with:

Options Overview Details

View History
  • Implied Volatility 78.00% ( -9.42%)
  • Historical Volatility 45.19%
  • IV Percentile 18%
  • IV Rank 22.16%
  • IV High 129.64% on 09/12/22
  • IV Low 63.30% on 09/01/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 3
  • Open Int (30-Day) 2

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.72
  • Number of Estimates 1
  • High Estimate -0.72
  • Low Estimate -0.72
  • Prior Year -0.76
  • Growth Rate Est. (year over year) +5.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.62 +13.37%
on 09/27/22
14.89 -19.11%
on 09/09/22
-0.72 (-5.64%)
since 09/02/22
3-Month
10.62 +13.37%
on 09/27/22
16.01 -24.80%
on 08/09/22
-3.14 (-20.69%)
since 07/01/22
52-Week
8.80 +36.82%
on 01/07/22
16.99 -29.13%
on 06/08/22
-1.00 (-7.67%)
since 10/01/21

Most Recent Stories

More News
RxSight, Inc. (RXST) Q2 2022 Earnings Call Transcript

RXST earnings call for the period ending June 30, 2022.

RXST : 12.04 (+0.33%)
RxSight, Inc. (RXST) Reports Q2 Loss, Tops Revenue Estimates

RxSight, Inc. (RXST) delivered earnings and revenue surprises of 26.47% and 0.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

RXST : 12.04 (+0.33%)
MASI : 144.54 (+2.39%)
RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program

ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 12.04 (+0.33%)
RxSight, Inc. Reports Second Quarter 2022 Financial Results

ALISO VIEJO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 12.04 (+0.33%)
RxSight, Inc. to Report Second Quarter 2022 Financial Results on August 8, 2022

ALISO VIEJO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 12.04 (+0.33%)
RxSight, Inc. (RXST) Q1 2022 Earnings Call Transcript

RXST earnings call for the period ending March 31, 2022.

RXST : 12.04 (+0.33%)
RxSight, Inc. to Present at the Bank of America Healthcare Conference

ALISO VIEJO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 12.04 (+0.33%)
Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting

ALISO VIEJO, Calif. , April 19, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 12.04 (+0.33%)
RxSight, Inc. to Present at the Needham Virtual Healthcare Conference

ALISO VIEJO, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the...

RXST : 12.04 (+0.33%)
RxSight, Inc. (RXST) Q4 2021 Earnings Call Transcript

RXST earnings call for the period ending December 31, 2021.

RXST : 12.04 (+0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens(R), RxSight Light Delivery Device and accessories. RxSight Inc. is based in ALISO VIEJO, Calif.

See More

Key Turning Points

3rd Resistance Point 13.32
2nd Resistance Point 12.80
1st Resistance Point 12.40
Last Price 12.04
1st Support Level 11.48
2nd Support Level 10.96
3rd Support Level 10.56

See More

52-Week High 16.99
Fibonacci 61.8% 13.86
Fibonacci 50% 12.90
Last Price 12.04
Fibonacci 38.2% 11.93
52-Week Low 8.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar